[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100474186":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":17,"responsibleParty":34,"collaborators":7,"id":36,"slug":37,"hasResults":38,"nctId":39,"briefTitle":40,"officialTitle":41,"acronym":7,"eligibilityCriteria":42,"healthyVolunteers":38,"sex":43,"minAge":7,"maxAge":7,"enrollmentInfo":44,"targetDuration":7,"studyType":47,"phases":7,"briefSummary":48,"conditions":49,"keywords":51,"overallStatus":19,"whyStopped":7,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":70},{"fullName":5,"class":6},"St. Jude Children's Research Hospital","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Dylan Graetz, MD","PRINCIPAL_INVESTIGATOR",[13],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},"CONTACT","888-226-4343","referralinfo@stjude.org",[18],{"facility":5,"status":19,"city":20,"state":21,"zip":22,"country":23,"countryCode":24,"cosmosGeoPoint":25,"geoPoint":30,"contacts":31},"RECRUITING","Memphis","Tennessee","38105","United States","US",{"type":26,"coordinates":27},"Point",[28,29],-90.04898,35.14953,{"lat":29,"lon":28},[32,33],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},{"name":10,"role":11,"phone":7,"phoneExt":7,"email":7},{"type":35,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100474186","the-decision-to-enroll-in-therapeutic-clinical-trials-in-a-pediatric-cancer-clinical-network-100474186",false,"NCT05454618","The Decision To Enroll In Therapeutic Clinical Trials In A Pediatric Cancer Clinical Network","U-DECIDE: The Decision To Enroll In Therapeutic Clinical Trials In A Pediatric Cancer Clinical Network","Inclusion Criteria:\n\n* All English or Spanish speaking parents\u002FLARs of patients 0-18 years of age with newly diagnosed cancer in the Affiliate network.\n\nExclusion Criteria:\n\n* Parents of children with relapsed or recurrent disease, or those with benign neoplasms.","ALL",{"count":45,"type":46},400,"ESTIMATED","OBSERVATIONAL","The focus of this study is to learn about the factors that parents consider when making a decision for their child to participate or not in a clinical treatment research study.",[50],"Knowledge, Attitudes, Practice",[52,53,54,55,56,57,58,59,60],"Parent","Pediatric Oncology Patients","Caregivers","Barriers to Enrollment on a Therapeutic Trial","Parent Navigator Program","Affiliate Network","Decision Making","Healthcare","Parent Engagement","2026-05-19",{"date":63,"type":64},"2026-05-20","ACTUAL",{"date":66,"type":64},"2022-10-04",{"date":68,"type":46},"2027-06",{"name":5,"class":6},1]